ABSTRACT
INTRODUCTION
DNA analysis has gained major diagnostic and therapeutic applications, leading to improved clinical diagnosis, treatment monitoring, and prognosis of diseases. This is mostly due to the major biotechnological developments over the past two decades. PCR, alone or in combination with sequence analysis and hybridization, has been the most commonly used and efficient analysis tool. With the greater availability of genomic information, the selective amplification and identification of multiple nucleotide sequences in a single assay have become critical issues. Multiparametric assays can be performed by multiplex PCR (2) . However, multiplex PCR requires the use of as many primers as the number of targets that must be amplified in the reaction. The presence of several primers hampers the amplification efficacy and increases the complexity, time, and cost of the assay (4, 15) . In addition to the amplification step, the detection of products is another pitfall of the multiparametric PCR process because the products must be different sizes using agarose gel, and real-time PCR is limited by the number of fluorochromes. DNA microarrays allow the simultaneous detection of multiple nucleotide sequences in a simple, miniaturized format assay and, in this way, could be considered for the detection of products (6, 7, 10) .
Here, we demonstrate that the technology of low-density microarrays can be linked with a consensus PCR for the amplification and detection of homologous sequences. Indeed, microorganisms of the same family or genus contain phylogenetically conserved genes that encode for the same protein. The sequences of the genes belonging to the same family are often highly homologous. Because of their homology, a consensus single pair of primers can be designed for their common amplification. The products would then be discriminated on the microarray.
The selected application was the identification of the staphylococcal bacteria and their methicillin resistance. This was chosen because of the increasing burden of nosocomial infections in hospitals. The assay combined the PCR amplification of the femAsequences, a highly conserved Staphylococcigene (14) encoding for a precursor of the peptidoglycan (5, 9, 12) , together with their analysis on a DNA microarray bearing capture probes, which were either specific for each species or being designed for genus identification.
We focused the species identification on S. aureusand four coagulasenegative Staphylococci (CoNS) strains ( S. epidermidis , S. haemolyticus , S. hominis , and S. Saprophyticus) , which, when taken together, represent the main cause of nosocomial infections and more than 95% of all the Staphylococci strains (8) . The identification of the mecA gene, a universal molecular marker for methicillin resistance (11, 13) , was added to the assay. Table 1 shows the 23 ATCC-type culture Staphylococci reference strains used in this study. They were provided by the
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Deutsche Sammlung von Mikroorganismen und Zellkulturen GmbH (DSMZ, Braunschweig, Germany).
Nucleotide Sequence Accession Numbers
The following nucleotide femAsequences have assigned GenBank ® accession nos. (AF144661, AF099964 
Cloning of femAFrom 16 Staphylococcus Species and of the mecASequence
The femAgenes from the 16 Staphylococcus -ATCC species were cloned in the TOPO ® -XL-PCR vector, according to the manufacturer's instructions (Invitrogen, Carlsbad, CA, USA) and assessed by sequencing analysis (16) . The mecA gene was cloned in the TOPO-XL-PCR vector. The bacterial strain used for the transformation was E. coliXL1-Blue. The extraction of plasmid DNA was performed with the Nucleobond ® AX100 kit (MachereyNagel GmbH, Düren, Germany). Bacterial strain cultures and DNA purifications were performed as previously described (17) . For the specificity tests, the plasmid DNA template quantity tested was 1 ng target sequence/tube. The reagents were first incubated at 94°C for 5 min and then cycled 40 times in a model 9600 thermal cycler (Applied Biosystems, Foster City, CA, USA) at 94°C for 30 s, 49°C for 45 s, and 72°C for 30 s. We performed a final extension step of 10 min at 72°C. The PCR products were directly used or stored at -20°C. The products were checked by loading 5 µ L product on a 2% (wt/vol) agarose gel. Electrophoresis was performed in 0.1 M Tris-HCl, pH 8.6, 80 mM boric acid, and 1 mM EDTA buffer containing 0.5 µ g ethidium bromide/mL. DNA fragments were visualized on a UV transilluminator at 300 nm. 
Low-Density Microarray Design
The low-density microarray, StaphyChips ® , was developed in collaboration with Advanced Array Technology (AAT) (Namur, Belgium) for the diagnosis of Staphylococci . The array is presented as a glass slide with the different capture nucleotide sequences covalently attached by an amino group located at the 5 ′ end onto an aldehyde functionalized slide (18) . The spots had 0.4-mm diameters. The array contained 10 detection capture probes present in quadruplicate: five Staphylococcal species, one for the genus Staphylococcus and one for the mecAand several controls. The positive hybridization control capture probe is related to products added to the hybridization solutions. The negative hybridization control is a nonspecific capture probe. The fixation controls are biotinylated capture probes that are spotted either at a high concentration or different concentrations. These four concentrations have been chosen to span between a high-and a low-labeled spot. It provides a good control of the detection efficiency.
The capture probe composition was specifically designed by the manufacturer, with the consensus one complementary to the femAproducts of S. hominis , while the species-specific capture probes, small capture probes of 27 bases, targeted the position 754-780 of each species-specific femA gene. The mecAcapture probe was complementary to its target sequence.
Hybridization and Colorimetric Detection
The procedure for detecting the PCR products was carried out according to the manufacturer's instructions (AAT): 5 µ L PCR product and 5 µ L of the positive control provided in the kit were denatured with 10 µ L fresh 0.175 N NaOH for 5 min at room temperature. This solution was then mixed with 35 µ L hybridization solution and loaded on the array framed by a hybridization chamber (Biozym, Landgraaf, The Netherlands). The chamber was sealed with a plastic coverslip, and hybridization was carried out for 30 min at 53°C. Slides were washed four times for 1 min with washing buffer. The glass samples were then incubated for 45 min at room temperature with streptavidin labeled with nanoparticles that were diluted 1000 times in blocking buffer. After five washes, the slides were incubated three times for 10 min with revelation mixture and then rinsed with water, dried, and scanned using a Workstation ® colorimetric microarray reader with quantification software (AAT).
The intensity of each spot was estimated by averaging the value of all pixels inside its boundaries. The value of the averaged background around the spot was subtracted from the spot values. Because the array was designed to have four replicates for each DNA probe, the value for a given probe was the average of the four replicates, more or less two SD . The last line of a spot was composed of a concentration curve of fixation control and was not treated as mentioned for the replicates. The cut-off value was set up at the intensity equal to five. This cut-off value was taken as the highest value obtained in all experiments for negative spots. The signals greater than this value were considered positive, and those under it were considered negative.
RESULTS
Consensus Amplification of the femANucleotide Sequences
Together with mecA Figure 1 presents the principle of low-density microarrays for the diagnosis of staphylococcal strains. The method combined the amplification of the femAtarget sequences using consensus primers, followed by their discrimination by hybridization on specific capture probes present on the array. A second Molecular DiagnosticTechniques Figure 1 . Principle of the two steps differential diagnosis of Staphylococcus . All femAsequences are PCR amplified using consensus primers, and the labeled products are discriminated on the DNA microarray by hybridization to capture probes specific for a given staphylococcal species or of the genus Staphylococcus .
primer pair for mecA , testing antibiotic resistance, was added in the reaction.
The femAgene has been sequenced i n 16 different Staphylococcus , and their sequence identity ranged from 66% to 85%. We took advantage of this homology to design partly degenerated consensus primers within two conserved regions of the femAgene. The predicted length of the femAPCR product was 587 bp. For the mecAgene, a specific primer pair with a melting temperature close to that of the femAprimers was chosen to avoid a constraint in the duplex PCR. The predicted length of the mecAproduct was 305 bp.
The PCR amplification of femAon the five species of interest and the mecAgene were first optimized separately and then adjusted to obtain similar efficiency when co-amplified in the duplex PCR. The optimized conditions are provided in the experimental protocol. After the optimization, the amplification of the femAmarker was validated on the following 16 Staphylococcal species: S . aureus , S . capitis , S . caseolyticus , S . cohnii , S . epidermidis , S . gallinarum, S . haemolyticus , S . hominis , S . intermedius , S .lugdunensis , S . saprophyticus , S . schleiferi , S. sciuri , S. simulans, S . warneri , and S . xylosus . In all samples, the same plasmid carrying the mecAgene was mixed with each of the 16 constructs carrying the speciesspecific femAsequence. Indeed, both products were simultaneously amplified in the 16 staphylococcal species as observed in agarose gel electrophoresis (data not shown). A weaker femAband was obtained for S . caseolyticus , which shows two and three mismatches within their femA segments, matching the primers and for S . lugdunensis , which shows five and two mismatches with the primers. The amplification of the 16 femAsequences with the same primers validated their use as consensus primers for the genus Staphylococcus .
Specificity of the Assay
Different parameters of the hybridization conditions, such as temperature, salt composition, denaturation mode, and incubation time, were optimized for both the detection specificity and sensitivity. The optimized conditions are given in the experimental protocols.
The specificity of the array was assessed by the hybridization of the PCR products from the 16 species-specific femAplasmids mixed with the plasmid carrying the mecAgene. Figure 2 presents an example of a microarray, resulting from the hybridization of femA sequence from S . aureus , S . epidermidis , S . haemolyticus , S . hominis , S . saprophyticus , and the mecAgene. The fixation and hybridization controls were correctly detected throughout the quadruplicates on the five slides. Each femAtarget sequence hybridized to its corresponding specific capture probe. There were no cross-hybridizations. The experiments were repeated five times and produced the same results. The absence of cross-hybridization of the capture probes specific of the five Staphylococcispecies was also observed with the femAof the other 11 Staphylococci species ( Figure 3A) . All of the negative PCR controls were clear. The specificity of the hybridization was made possible because of high variability within a portion of the femA genes (positions 754-780), which was targeted by the species-specific capture probes. The identity expressed as the minimum and maximum number of mismatches between each of the capture probes and the five other femAsequences were as follows: S . aureus (8) (9) (10) (11) (12) (13) (14) (15) (16) , S . epidermidis (3) (4) (5) (6) (7) (8) (9) (10) (11) (12) (13) (14) (15) (16) (17) , S . haemolyticus (8) (9) (10) (11) (12) (13) (14) (15) (16) , S . hominis (9) (10) (11) (12) (13) (14) (15) , and S . saprophyticus (6) (7) (8) (9) (10) (11) (12) (13) (14) . In all cases, a minimum of three mismatches was present, which explains the perfect discrimination observed.
In contrast to the specificity given by the capture probes for the five species, all 16 femA products hybridized to the genus capture probe ( Figure 3B minis femAsequence. The sequence homology of all the femAsequences with this capture probe was higher than 76%, the lowest one being the femA from S . caseolyticus . The variations of the absolute values are probably the result of differences in the PCR amplification and hybridization efficiencies. The detections of the mecA sequence in the same 16 samples were positive and ranged in absolute value between 93 and 22 gray intensity for the 16 Staphylococci species, with an average value of 62 and a CV of 25%. In this case, the target sequences are identical and perfectly matched with the capture probe. Because the mecA is identical in all samples and the same PCR product volume was hybridized on the arrays, these variations are probably due to the competition in the duplex PCR with the femAamplifications.
The assay specificity was further investigated using 18 ATCC-type culture strains of CoNS and five non-staphylococcal strains. The extracted DNA was PCR amplified, and the products were hybridized to the StaphyChips. The molecular identifications were compared to conventional microbiological assays (Table 1) . For the products from the 18 Staphylococcus -ATCC strains, we correctly identified the genus Staphylococcus , the methicillin resistance, and the five specific, targeted staphylococcal species. No cross-species identifications were observed, and all the negative PCR controls were clear.
Sensitivity of the Assay on S. aureus femAand mecAPlasmid DNA
The detection limit of the assay was assessed using increasing copy numbers of S . aureus femAand mecAplasmid DNA, ranging from 10 to 10 8 . After PCR amplification and microarray analysis, a detection limit of 10 4 copies was obtained for the signal corresponding to the genus Staphylococcusand 10 3 copies for the S . aureus signal (Figure 4) . For the mecA , the lowest significant signal was obtained for 10 copies. These detection limits were obtained in two distinct experiments, even if the present experiment did not show a clear linearity between the signals and the dilution in the 10-1000 copies range. The PCR negative controls were clear.
DISCUSSION
The discovery of new genes and the increasing number of sequences available in public databases lead to the need for multiparametric molecular analytic tools. Microarrays are good candidates, given the miniaturization and the large number of capture probes that can be present on a small surface. Alternatively, PCR is the method of choice for the amplification of DNA sequences. To combine both methods for the analysis of a large number of sequences, it is useful to amplify the sequences with one or a small number of consensus primers. This is only possible if the target sequences are homologous. The most conserved parts of the sequence can then serve as the consensus primers to amplify all the sequences, while the most variable parts provide the specificity of the hybridization to the array.
In this paper, we applied this concept to the detection of femADNA sequences that are molecular markers for the staphylococcal species (14) . Using consensus primers, we obtained the amplification of all 16 staphylococcal species, with differences in the amplification efficiencies. Additional primers specific for the methicillin-resistant determinant (11, 13) , mecAsequence, were added so that both molecular markers were amplified in a single duplex PCR. The microarrays analyses gave the expected responses and allowed the correct identification of the five most representative staphylococcal species, with no cross-reaction among the species. The use of a single capture probe for each specific identification allows the straightforward interpretation of the results. The presence of the 11 other staphylococcal species that are not of clinical relevance was obtained by a positive signal on a single staphylococcal consensus capture probe ( Figure 3B ). These results clearly demonstrated that long homologous sequences can be targeted to consensus capture probes, while discrimination between the homologous sequences was possible on a small protion sequence, as exemplified on the species-specific capture probes. However, from a quantitative point of view, the amplification and detection on microarrays did not lead to the same signal for the 16 sequences. The variations in intensity resulted not only from the differences in the PCR efficiency caused by the use of consensus primers but also of the hybridization yield, and this for a capture probe either long as consensus for the genus identification or short as for the species identification. Such variations are intrinsic to the methodology.
The detection limit of the assay was lower than 10 4 copies of plasmid DNA. To identify false-negative PCR results caused by enzymatic inhibition, further exogenous internal controls could be added to the sample before the reaction. In the optimized protocol, the array hybridization, washing, and detection time were reduced to 2 h. Overall, the time required to get a final result including extraction and DNA amplification is 6 h, while conventional genus, species, and resistance identification takes 1-3 days. This gain of time largely compensates for the higher price of the molecular assay.
The colorimetric detection method based on silver staining coloration was specific, inexpensive, and highly sensitive, which makes it suitable for routine use (1). A similar approach for the identification of Staphylococcushas been recently proposed based on the amplification of the 23S ribosomal DNA. However, in most cases, several capture probes were necessary for the identification of one species because of the similarity between the sequences (3).
In conclusion, we show one methodology of using low-density microarrays as a molecular diagnostic tool. The StaphyChips were developed for the genus Staphylococcus , but the same methodology can be applied for each bacterial genus, thus opening the door to molecular bacterial diagnosis. The limited number of analytical data and the univocal response of such low-density arrays provide rapid answers to some clinically relevant issues, thus contributing to better infected patient isolation and therapeutic policy. The discriminating power of the assay can be extended by adding capture probes to the panel, without significantly increasing the complexity or cost of the assay. Further automation of the three parts of the assay (i.e., DNA extraction, PCR amplification, and hybridization detection) is expected to further speed up the analytical procedure. This will make this approach a possible candidate technology aimed to convert the actual taxonomic analysis based on biochemical characters into the rapid molecular identification of bacterial species and genus.
